Assessing the cost-effectiveness of adding aprepitant to the ASCO standard for prophylaxis of chemotherapy induced nausea and vomiting
2005
6009 Background: Chemotherapy-induced nausea and vomiting (CINV) is cited as a great concern for cancer patients. ASCO guidelines for prophylaxis of CINV in patients receiving highly-emetogenic che...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI